Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02022553Not ApplicableCompleted

Procedure RACHEL in Complex Treatment of Rectal Cancer

Role: lead

NCT06392334Not ApplicableRecruiting

Mast Cells and Its Proteases in COPD

Role: lead

NCT01876537Not ApplicableCompleted

Hardware Wound Healing In Surgical Treatment Of Sacrococcygeal Pilonidal Sinus Disease

Role: lead

NCT04239118Not ApplicableCompleted

New Technologies for Endoscopic Treatment of Bleeding Gastroduodenal Ulcers

Role: lead

NCT04105075Completed

COPD in Obese Patients

Role: lead

All 5 trials loaded